J&J vaccine study to resume in South Africa on Wednesday, ministry says

PUBLISHED: Mon, 26 Apr 2021 05:41:44 GMT
Share

JOHANNESBURG, April 26 (Reuters) – A research study in South Africa further evaluating Johnson & Johnson’s COVID-19 vaccine in the field will resume on Wednesday, the health ministry said, after the study was paused over rare cases of blood clots in people given the vaccine.

During the pause, it had been established that there is a one in a million chance of getting a clot after the vaccine, so regulators across the world have recommended the continued use of J&J’s shot, the ministry said.

Local regulator SAHPRA, the South African Medical Research Council and health ministry have worked to ensure there is intensified pre-vaccination assessment and post-vaccination monitoring when the J&J study resumes, it added.

(Reporting by Alexander Winning Editing by Nqobile Dludla)

(c) Copyright Thomson Reuters 2021. Click For Restrictions – https://agency.reuters.com/en/copyright.html

Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.